Youngran Park

877 citations
31 papers · 658 indexed · h-index 15
Topics
Asthma and respiratory diseases (4 papers)Galectins and Cancer Biology (3 papers)Natural product bioactivities and synthesis (3 papers)

In The Last Decade

Youngran Park

28 papers receiving 645 citations

Peers

Youngran Park
Comparison fields: 5 of 87
  • Molecular Biology 331
  • Immunology 245
  • Oncology 169
  • Cancer Research 75
  • Pathology and Forensic Medicine 73
Replace Hsin‐Yi Tseng with:
Hsin‐Yi Tseng Australia
Coral Ampurdanés Spain
Diana Saleiro United States
Sheri L. Bonar United States
Christa Pfeifhofer‐Obermair Austria
Li-Yuan Bai Taiwan
Yueping Sun China
Venkatesh V. Nemmara United States
Chao He China
Youngran Park relative to Hsin‐Yi Tseng Australia Hsin‐Yi Tseng's profile →
Citations per field
00.5×1.5×
Hsin‐Yi Tseng · 1×
Citations per year

Countries citing papers authored by Youngran Park

Since Specialization
Citations

This map shows the geographic impact of Youngran Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youngran Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youngran Park more than expected).

Fields of papers citing papers by Youngran Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youngran Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youngran Park. The network helps show where Youngran Park may publish in the future.

Co-authorship network of co-authors of Youngran Park

This figure shows the co-authorship network connecting the top 25 collaborators of Youngran Park. A scholar is included among the top collaborators of Youngran Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youngran Park. Youngran Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 17
4 94
5 5
6 7
7 95
8 16
9 4
10 2
11 4
12 24
13 13
14
Association of the Human IL-28RA Gene Polymorphisms in a Korean Population with Asthma
1
15 16
16 69
17 41
18 24
19 46
20 33

About Youngran Park

Youngran Park is a scholar working on Immunology, Toxicology and Emergency Medical Services, having authored 31 papers that have together received 658 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Galectins and Cancer Biology (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Immunology (245 citations), Oncology (169 citations) and Physiology (27 citations). Youngran Park has collaborated with scholars based in South Korea, United States and Norway. Frequent co-authors include Soo‐Cheon Chae, Hun‐Taeg Chung, Seung Cheol Shim, Kyung‐Sik Yoon, Jae Hoon Lee, Yong‐Chul Lee, Jeesoo Kim, Ahyeon Son, V. Narry Kim and Young-Suk Lee. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026